These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization. Fox GB; Pan JB; Radek RJ; Lewis AM; Bitner RS; Esbenshade TA; Faghih R; Bennani YL; Williams M; Yao BB; Decker MW; Hancock AA J Pharmacol Exp Ther; 2003 Jun; 305(3):897-908. PubMed ID: 12606600 [TBL] [Abstract][Full Text] [Related]
6. Achievement of behavioral efficacy and improved potency in new heterocyclic analogs of benzofuran H3 antagonists. Cowart M; Faghih R; Gfesser G; Curtis M; Sun M; Zhao C; Bennani Y; Wetter J; Marsh K; Miller TR; Krueger K; Pan JB; Drescher K; Fox GB; Esbenshade TA; Hancock AA Inflamm Res; 2005 Apr; 54 Suppl 1():S25-6. PubMed ID: 15928820 [No Abstract] [Full Text] [Related]
7. Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia? Ellenbroek BA; Ghiabi B Curr Pharm Des; 2015; 21(26):3760-70. PubMed ID: 26044979 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of 5-amino- and 5-(aminomethyl)benzofuran histamine H3 receptor antagonists with improved potency. Sun M; Zhao C; Gfesser GA; Thiffault C; Miller TR; Marsh K; Wetter J; Curtis M; Faghih R; Esbenshade TA; Hancock AA; Cowart M J Med Chem; 2005 Oct; 48(20):6482-90. PubMed ID: 16190774 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties. Esbenshade TA; Fox GB; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan L; Wetter J; Marsh K; Bennani YL; Cowart MD; Sullivan JP; Hancock AA J Pharmacol Exp Ther; 2005 Apr; 313(1):165-75. PubMed ID: 15608078 [TBL] [Abstract][Full Text] [Related]
10. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs. Zhang M; Ballard ME; Pan L; Roberts S; Faghih R; Cowart M; Esbenshade TA; Fox GB; Decker MW; Hancock AA; Rueter LE Brain Res; 2005 May; 1045(1-2):142-9. PubMed ID: 15910772 [TBL] [Abstract][Full Text] [Related]
11. Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse. Provensi G; Costa A; Passani MB; Blandina P Neuropharmacology; 2016 Oct; 109():139-147. PubMed ID: 27291828 [TBL] [Abstract][Full Text] [Related]
12. Histamine-selective H3 receptor ligands and cognitive functions: an overview. Vohora D IDrugs; 2004 Jul; 7(7):667-73. PubMed ID: 15243869 [TBL] [Abstract][Full Text] [Related]
14. Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition. Brown DG; Bernstein PR; Griffin A; Wesolowski S; Labrecque D; Tremblay MC; Sylvester M; Mauger R; Edwards PD; Throner SR; Folmer JJ; Cacciola J; Scott C; Lazor LA; Pourashraf M; Santhakumar V; Potts WM; Sydserff S; Giguère P; Lévesque C; Dasser M; Groblewski T J Med Chem; 2014 Feb; 57(3):733-58. PubMed ID: 24410637 [TBL] [Abstract][Full Text] [Related]
15. Effects of the histamine H₃ receptor antagonist ABT-239 on cognition and nicotine-induced memory enhancement in mice. Kruk M; Miszkiel J; McCreary AC; Przegaliński E; Filip M; Biała G Pharmacol Rep; 2012; 64(6):1316-25. PubMed ID: 23406742 [TBL] [Abstract][Full Text] [Related]
16. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects. Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603 [TBL] [Abstract][Full Text] [Related]